Aprizo 30 Tablet

About Aprizo 30 Tablet

Aprizo 30 is a 30 mg tablet made by Nuvista Pharma Ltd that contains the medicine apremilast. It is a disease-modifying antirheumatic drug taken by adults for certain long-term skin and joint conditions.

There are 5 brands of Apremilast listed in Bangladesh.

What is Aprizo 30 Tablet?

Aprizo 30 is an oral tablet containing 30 mg of apremilast, supplied by Nuvista Pharma Ltd. It belongs to a group of medicines called disease-modifying antirheumatic drugs. It works on an enzyme involved in inflammation inside the body rather than on a single symptom. Doctors prescribe it for adults with active psoriatic arthritis and for adults with moderate to severe plaque psoriasis who are suitable for phototherapy or systemic therapy. Because it is used for long-term conditions, regular follow-up with your doctor matters. Ask your doctor or pharmacist if you have questions about whether it suits your condition.

Uses of Aprizo 30

Aprizo 30 is used in adults for two conditions. One is active psoriatic arthritis, a joint problem linked with the skin condition psoriasis. The other is moderate to severe plaque psoriasis in people who are candidates for phototherapy or systemic therapy. It is not a quick relief medicine for pain or itching. Your doctor will confirm whether it is appropriate for you, since it is not meant for everyone with skin or joint symptoms.

How to use Aprizo 30

Swallow the tablet with water. Your doctor decides the dose, how often you take it and how long the course lasts, and may start with a lower strength before moving to the regular tablet. Aprizo 30 can be taken with or without food. Do not change the amount or stop on your own, even if you feel better. If you miss a dose or are unsure, ask your doctor or pharmacist what to do.

Side effects of Aprizo 30

The most common side effects are nausea, diarrhoea and headache. Others include vomiting, upper respiratory tract infection, sore throat and nasal symptoms, stomach pain, heartburn, indigestion, tiredness, reduced appetite, cough, rash, trouble sleeping and allergic reactions. Some people notice mood changes or weight loss. Tell your doctor or pharmacist if any side effect bothers you or does not settle, and get medical help for severe or unusual symptoms.

Safety and precautions

Do not take Aprizo 30 if you have had an allergic reaction to apremilast or to any ingredient in the tablet. It can be linked with depression, suicidal thoughts or other mood changes, so you, your family and carers should watch for these and contact your doctor if they appear. Weight loss has been reported. Apremilast is pregnancy category C, and it is not known whether it passes into human breast milk, so tell your doctor if you are pregnant, planning pregnancy or breastfeeding. Also tell your doctor about other medicines you take, including rifampin, phenobarbital, carbamazepine or phenytoin, and ask about your own risks before starting.

Frequently asked questions

How should I store Aprizo 30 tablets?

Keep the tablets in a cool, dry place away from light and moisture. Leave them in their original packaging and out of the reach of children. Do not use them after the expiry date, and ask your pharmacist how to dispose of any tablets you no longer need.

What is Aprizo 30 used for and what kind of medicine is it?

It is a disease-modifying antirheumatic drug containing apremilast. Doctors use it in adults for active psoriatic arthritis and for moderate to severe plaque psoriasis in people who are candidates for phototherapy or systemic therapy. Ask your doctor if it is suitable for your condition.

How should I take Aprizo 30?

Take the tablet by mouth with water, with or without food. Your doctor decides the dose, how often you take it and the length of the course, and may begin with a lower strength. Never change the dose or stop the medicine without your doctor's advice.

Who should check with a doctor before taking Aprizo 30?

Tell your doctor if you have ever had an allergic reaction to apremilast, if you have depression or mood problems, or if you are pregnant, planning pregnancy or breastfeeding. Also mention all other medicines you take, as some can interfere with this medicine. Your doctor will advise you.

Indications

Apremilast is indicated for the treatment of adult patients with active psoriatic arthritis and moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.

Pharmacology

Apremilast is a novel, orally available small molecule inhibitor of type-4 cyclic nucleotide phosphodiesterase (PDE-4). PDE-4 is a cyclic adenosine monophosphate (cAMP)-specific phosphodiesterase that is predominantly located in inflammatory cells. By inhibiting PDE-4, apremilast increases intracellular levels of cAMP and thereby inhibits the production of multiple proinflammatory mediators including PDE-4, TNF-alpha, interleukin-2 (IL-2), interferon-gamma, leukotrienes, and nitric oxide synthase. By targeting a central component of the inflammatory signaling cascade rather than a single inflammatory marker, PDE-4 inhibition may restore the homeostatic balance between pro- and anti-inflammatory signalling.

Dosage & Administration

The recommended initial dosage titration of Apremilast from Day 1 to Day 5 is shown below. Following the 5-day titration, the recommended maintenance dosage is 30 mg twice daily taken orally starting on Day 6. This titration is intended to reduce the gastrointestinal symptoms associated with initial therapy. Apremilast can be administered without regard to meals.

Day 1: 10 mg in morning
Day 2: 10 mg in morning and 10 mg in evening
Day 3: 10 mg in morning and 20 mg in evening
Day 4: 20 mg in morning and 20 mg in evening
Day 5: 20 mg in morning and 30 mg in evening
Day 6: 30 mg twice daily

Dosage adjustment in patients with severe renal impairment. Apremilast dosage should be reduced to 30 mg once daily in patients with severe renal impairment. For initial dosage titration, it is recommended that Apremilast be titrated using only the morning schedule and the evening doses be skipped.

Interaction

Co-administration of strong cytochrome P450 enzyme inducer Rifampin resulted in a reduction of systemic exposure of Apremilast.Therefore.the use of cytochrome P450 enzyme inducers (e.g. Rifampin, Phenobarbital,Carbamazepine, Phenytoin) with Apremilast is not recommended.

Contraindications

Apremilast is contraindicated in patients with a known hypersensitivity to Apremilast or to any of the excipients in the formulation.

Side Effects

The most frequently occurring side effects of Apremilast are nausea, diarrhea and headache. Other less frequent side effects are upper respiratory tract infection, vomiting, naospharyngitis, abdominal pain, hypersensitivity, gastroesophageal reflux disease, dyspepsia, fatigue, decrease appetite, cough, rash, insomnia.

Pregnancy & Lactation

Pregnancy Category C. It is not known whether Apremilast or its metabolites are present in human milk; however, Apremilast was detected in milk of lactating mice. Caution should be exercised when Apremilast is administered to a nursing woman.

Precautions & Warnings

Treatment with Apremilast is associated with an increase in adverse reactions of depression. Patients, their caregivers and families should be advised of the need to be alert for the emergence or worsening of depression, suicidal thoughts or other mood changes and if such changes occur to contact their healthcare provider. Prescribers should carefully evaluate the risks and benefits of continuing treatment with Apremilast if such events occur.

During the controlled period of the studies in psoriatic arthritis, weight decrease between 5-10% of body weight was reported in 10% of subjects treated with Apremilast 30 mg twice daily compared to 3.3% treated with placebo.

Storage Conditions

Store at cool & dry place, protected from light & moisture. Keep the medicine out of the reach of children.

Alternative brands of Apremilast

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.